Pharmacists' experience with prescribing hormonal contraception in Oregon



      To describe Oregon pharmacy practices in provision of hormonal contraception (HC) and evaluate if pharmacists' motivation to prescribe changed after 6 and 12 months of experience.


      Pharmacists practicing in Oregon who underwent the mandatory HC training were eligible to take this survey. The survey was launched 6 months after policy implementation; pharmacists who responded to the initial survey were eligible to be queried again at 12 months. Survey responses were anonymous, but pharmacists received a unique identifier so that responses could be linked between the 2 surveys. The survey consisted of pharmacy and pharmacist demographics and questions exploring attitudes toward prescribing HC and prescribing practices (e.g., cost, time needed for visit) and volume estimates. Descriptive statistics were used to analyze responses as well as the differences in key outcomes between 6 and 12 months.


      A total of 732 pharmacists were eligible to take the survey; 121 pharmacists responded to the 6-month survey (16.5% response rate), and 62 completed the 12-month survey (52% response rate). A large increase in the distribution of pharmacists prescribing HC by zip code occurred between 6 and 12 months: 19% and 63%, respectively. At both 6 and 12 months, almost one-half of all pharmacists were billing insurance for the visit, and the average visit took less than 30 minutes. The top 3 motivators for providing HC did not change over time and included increasing access, reducing unintended pregnancy, and increasing pharmacist scope of practice.


      One year after program implementation, pharmacist prescribing of HC continues to increase and is distributed widely across the state. A geographically diverse sample of Oregon pharmacists began prescribing of hormonal contraception within 12 months of Oregon's implementation of the new pharmacist provision policy. Their experience and the success of the program provide a roadmap for pharmacist participation to increase access to hormonal contraception.
      To read this article in full you will need to make a payment
      APhA Member Login
      APhA Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Grossman D.
        Moving oral contraceptives over the counter as a strategy to reduce unintended pregnancy.
        Ann Intern Med. 2013; 158: 839-840
        • Grossman D.
        • Fuentes L.
        Over-the-counter access to oral contraceptives as a reproductive healthcare strategy.
        Curr Opin Obstet Gynecol. 2013; 2: 500-505
        • Finer L.B.
        • Henshaw S.K.
        Disparities in rates of unintended pregnancy in the United States, 1994 and 2001.
        Perspect Sex Reprod Health. 2006; 3: 90-96
        • Finer L.B.
        • Zolna M.R.
        Unintended pregnancy in the United States: incidence and disparities, 2006.
        Contraception. 2011; 8: 478-485
        • Sonfield A.
        • Kost K.
        • Gold R.B.
        • Finer L.B.
        The public costs of births resulting from unintended pregnancies: national and state-level estimates.
        Perspect Sex Reprod Health. 2011; 4: 94-102
        • Frost J.J.
        • Singh S.
        • Finer L.B.
        Factors associated with contraceptive use and nonuse, United States, 2004.
        Perspect Sex Reprod Health. 2007; 3: 90-99
        • Frost J.J.
        • Singh S.
        • Finer L.B.
        U.S. women's one-year contraceptive use patterns, 2004.
        Perspect Sex Reprod Health. 2007; 3: 48-55
        • National Alliance of State Pharmacy Associations
        Pharmacists authorized to prescribe birth control in more states.
        VA: NASPA, North Chesterfield2017 (Available at:) (Accessed January 18, 2018)
        • Rodriguez M.I.
        • Anderson L.
        • Edelman A.B.
        Prescription of hormonal contraception by pharmacists in Oregon: implementation of House Bill 2879.
        Obstet Gynecol. 2016; 12: 168-170
        • World Health Organization
        Medical eligibility criteria for contraceptive use.
        Geneva, 2015
        • Rodriguez M.I.
        • McConnell K.J.
        • Swartz J.
        • Edelman A.B.
        Pharmacist prescription of hormonal contraception in Oregon: baseline knowledge and interest in provision.
        J Am Pharm Assoc (2003). 2016; 5: 521-526
        • Landau S.
        • Besinque K.
        • Chung F.
        • Dries-Daffner I.
        • Maderas N.M.
        • McGhee B.T.
        • et al.
        Pharmacist interest in and attitudes toward direct pharmacy access to hormonal contraception in the United States.
        J Am Pharm Assoc (2003). 2009; 4: 43-50
        • Norman W.V.
        • Soon J.A.
        • Panagiotoglou D.
        • Albert A.
        • Zed P.J.
        The acceptability of contraception task-sharing among pharmacists in Canada—the ACT-Pharm study.
        Contraception. 2015; 9: 55-61
        • Oregon Office of Rural Health
        ORH urban/rural areas. December 18, 2012.
        (Available at:) (Accessed January 18, 2018)
      1. Open Source Geospatial Foundation Project. QGIS: geographic information system.
        (Available at:) (Accessed January 18, 2018)
        • Oregon State University, State of Oregon
        Oregon spatial data library: Oregon zip code areas.
        OR, Corvallis2016 (Available at:) (Accessed January 18, 2018)
        • Oregon State University, State of Oregon
        Oregon spatial data library: major cities.
        OR, Corvallis2016 (Available at:) (Accessed January 18, 2018)
        • United States Census Bureau
        Cartographic boundary shapefiles—census tracts.
        PA: U.S. Census Bureau, Philadelphia2017 (Available at:) (Accessed January 18, 2018)
        • Office of Policy Development and Research, U.S. Department of Housing and Urban Development
        USPS zip code crosswalk files.
        (Available at:) (Accessed January 18, 2018)
        • Gomez A.M.
        Availability of pharmacist-prescribed contraception in California, 2017.
        JAMA. 2017; 318: 2253-2254
      2. Vu K, Rafie S, Grindlay K, Gutierrez H, Grossman D. Pharmacist intentions to prescribe hormonal contraception following new legislative authority in California. J Pharm Pract. 20(17):897190017737897.


      Maria I. Rodriguez, Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR


      Frances M. Biel, Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR


      Jonas J. Swartz, Obstetrics and Gynecology, Oregon Health and Science University; Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC


      Lorinda Anderson, College of Pharmacy, Oregon State University, Corvallis, OR


      Alison B. Edelman, Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR